Treatments for gestational diabetes: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Objective: To investigate the effectiveness of different treatments for gestational diabetes mellitus (GDM). Design: Systematic review, meta-analysis and network meta-analysis. Methods: Data sources were searched up to July 2016 and included MEDLINE and Embase. Randomised trials comparing treatments for GDM (packages of care (dietary and lifestyle interventions with pharmacological treatments as required), insulin, metformin, glibenclamide (glyburide)) were selected by two authors and double checked for accuracy. Outcomes included large for gestational age, shoulder dystocia, neonatal hypoglycaemia, caesarean section and pre-eclampsia. We pooled data using random-effects meta-analyses and used Bayesian network meta-analysis to compare pharmacological treatments (ie, including treatments not directly compared within a trial). Results: Forty-two trials were included, the reporting of which was generally poor with unclear or high risk of bias. Packages of care varied in their composition and reduced the risk of most adverse perinatal outcomes compared with routine care (eg, large for gestational age: relative risk0.58 (95% CI 0.49 to 0.68; I 2 =0%; trials 8; participants 3462). Network meta-analyses suggest that metformin had the highest probability of being the most effective treatment in reducing the risk of most outcomes compared with insulin or glibenclamide. Conclusions: Evidence shows that packages of care are effective in reducing the risk of most adverse perinatal outcomes. However, trials often include few women, are poorly reported with unclear or high risk of bias and report few outcomes. The contribution of each treatment within the packages of care remains unclear. Large well-designed and well-conducted trials are urgently needed. Trial registration number: PROSPERO CRD42013004608.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DM during pregnancy and even maternal obesity itself1418 set the stage for a vicious cycle with offspring of mothers with DM during pregnancy being more likely to become obese and to develop DM at younger ages.1420”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The HAPO study confirmed findings in Pima Indians1409 that, even among offspring of women without GDM as it is currently defined, there is a linear association between maternal glucose concentration during pregnancy and newborn weight, rates of large-for-gestational-age, and cesarean delivery.64,1418–1421”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1420]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment of higherthreshold maternal hyperglycemia, as identified by the two-step approach, reduces rates of neonatal macrosomia, large-forgestational-age births (207), and shoulder dystocia without increasing small-forgestational-age births.”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [207]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A package of care (a combination of treatments starting with dietary modifications and/or exercise and/or pharmacological treatments) is effective in reducing the risk of most adverse perinatal outcomes of GDM, but the evidence is of low quality245.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [245]
In the citing paper
“A meta-analysis found poorly reported results and potential bias from randomized trials comparing treatments for GDM [11].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Combination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Research works printed but not linked: 4
- Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking a systematic review York: CRD, University of York, 2009.
- Zinnat ANS, Shareen S, Rahman S Can metformin be used in place of insulin for the treatment of GDM for low resource countries? BJOG 2013; 120: 35.
- Ijäs H, Vääräsmäki M, Morin-Papunen L, et al Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 2011; 118: 880– 5. 10.1111/j.1471-0528.2010.02763.x 21083860 · DOI · Paper page
- O’Sullivan JB, Mahan CM Diabetes 1967; 13: 278– 85. 14166677
Cited by
Items 101–169 of 169
Saraiva, M., Fonseca, L., Santos, T., Vilaverde, J., Pereira, M. T., Pichel, F., Pinto, C., Almeida, M., & Dores, J. M. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01714-w · Cited by 7
Wu, D., Zou, S., Chen, H., Li, X., Xu, Y., Zuo, Q., Pan, Y., Jiang, S., Huang, H., & Sun, L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.10.013 · Cited by 7
Gestational Diabetes: A Review
Barbach, A., Chenguiti, A. A., Charrah, Y., & Barkat, A. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2649 · Cited by 7
Zade, S. R., Khasbage, S. U., Mishra, A., & Mehani, R. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101442 · Cited by 9
Grønvall, L., & Skjeldestad, F. E. (2021) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14276 · Cited by 8
McCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Suboptimally Controlled Diabetes in Pregnancy: A Review to Guide Antepartum and Delivery Management
Cate, J. J. M., Bloom, E. A., Chu, A., Bauer, S., Kuller, J. A., & Dotters-Katz, S. K. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001270 · Cited by 7
“55 They suggest that there is evidence to favor metformin over insulin or glyburide, but the included studies are of small sample size and poor quality, limiting conclusions.”
BackgroundAgarwal, S. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3.1457 · Cited by 11
The new gestational diabetes: Treatment, evidence and consent
Hegerty, C. K. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13116 · Cited by 8
Yu, Y., Platt, R. W., Reynier, P., Yu, O. H. Y., & Filion, K. B. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16115 · Cited by 6
Sivadasan, S., Subramanian, M., & Aiyalu, R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99815 · Cited by 5
“GDM is associated with short- and long-term sequelae on both, mother and offspring [37, 38].”
BackgroundGestational Diabetes Mellitus Management Among Primigravida Women: A Qualitative Study
Rath, K., & Smitha, M. V. (2025) · Cureus · doi:10.7759/cureus.88710 · Cited by 5
“GDM is associated with a spectrum of adverse outcomes, including macrosomia, birth trauma, preeclampsia, increased caesarean section rates, and neonatal complications such as hypoglycaemia and respiratory distress syndrome [6].”
Bogdanet, D., Castillo, M. T., Doheny, H. C., Dervan, L., Luque-Fernández, M. Á., Halperin, J. A., O’Shea, P. M., & Dunne, F. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01983-z · Cited by 4
“A possible explanation for this is the treatment-effect, women with a formal GDM diagnosis receiving treatment thus reducing the risk of adverse outcomes, a finding supported by other studies [36, 37].”
ResultD’Souza, A., Abdullahi, H., Badri, F., & Ibrahim, I. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07869-6 · Cited by 5
“In contrast, some studies have reported that metformin use is associated with less gestational hypertension [34, 35] and preeclampsia [36] compared to insulin.”
Hegerty, C. K., & Ostini, R. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069849 · Cited by 4
Recurrent gestational diabetes: Breaking the transgenerational cycle with lifestyle modification
Liney, T. E. J., Shah, N. M., & Singh, N. (2022) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02004-3 · Cited by 4
“indirect markers of improvements in maternal and neonatal health measured by metabolomic and epigenetic changes [104].”
BackgroundMarkussen, L. T., Kivelä, J., Lindström, J., Ollikainen, M., Kytö, M., Heinonen, S. T., Koivusalo, S. B., & Meinilä, J. M. (2025) · BMC Nutrition · doi:10.1186/s40795-024-00988-x · Cited by 2
“Currently, the first-line treatment for GDM is dietary intervention for glycaemic control [16, 17] alongside daily physical activity and self-monitoring of blood glucose (SMBG) [16].”
Assessment of Maternal–Fetal Redox Balance in Gestational Diabetes Mellitus: A Cross-Sectional Study
Chelu, S. C., Chiriac, V. D., Andrei, D., Stoicescu, E. R., & Borza, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14197003 · Cited by 2
Rol de la metformina en el tratamiento de la diabetes mellitus gestacional: situación actual
Miranda, P. J. P., Palacios, L. P. T., Cueva, J. L. C., Avilés, G. A. H., Maldonado, E. I. B., Moya, J. I. E., Moya, J. R. E., Acosta, J. M. S., & Lozada, E. M. V. (2019) · Archivos Venezolanos de Farmacología y Terapéutica · Cited by 10
Diabetes During Pregnancy: Neonatal and Childhood Complications
van der Beek, E. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_17 · Cited by 2
Lei, S. K., Wong, C. L., Leung, K. P., & Shum, T. C. (2023) · Medicine · doi:10.1097/md.0000000000035175 · Cited by 5
Alzaben, A. S., Bawazeer, N. M., Almoayad, F. A., Benajiba, N., Dodge, E., & Aboul-Enein, B. H. (2025) · Midwifery · doi:10.1016/j.midw.2025.104453 · Cited by 2
Cross-sectional Study of Glucose Disturbances of Pregnant Women in Bulgaria
Borissovа, A.-M., Trifonova, B., Dakovska, L. N., Mihailova, E., & Vukov, M. (2021) · Clinical Medicine Research · doi:10.11648/j.cmr.20211001.12 · Cited by 2
“After specifying the disturbances of glucose tolerance, a certain algorithm is followed and the first step should be the introduction of appropriate diet and physical activity, and only then come the possible other therapeutic interventions [8, 9].”
MethodAntidiabéticos orais no diabetes gestacional: revisão de literatura
Araújo, P. H. D. A., Gregio, A. C. D. A. R., Scárdua, J. D. L. M., & Trindade, C. R. (2021) · Femina · doi:10.61622/0100-7254493202107 · Cited by 17
Weight gain in pregnancy: can metformin steady the scales?
Adams, J. H., Poehlmann, J. R., Racine, J. L., Iruretagoyena, J. I., Eddy, A., Hoppe, K. K., Stewart, K. S., Rhoades, J. S., & Antony, K. M. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2044775 · Cited by 3
“natal hypoglycemia, preeclampsia, and gestational hypertension [10].”
Continuing Challenges in The Medical Management of Gestational Diabetes Mellitus
Jiang, S., Rajagopal, R., & Simmons, D. S. (2020) · EMJ Diabetes · doi:10.33590/emjdiabet/20-00003 · Cited by 5
Yanachkova, V. E., Staynova, R. A., Stoev, S., & Kamenov, Z. A. (2023) · Ginekologia Polska · doi:10.5603/gpl.91632 · Cited by 2
Das metabolische Syndrom und Schwangerschaft
Mayer-Pickel, K. I. (2020) · Journal für Gynäkologische Endokrinologie/Österreich · doi:10.1007/s41974-020-00169-1 · Cited by 1
Pivoto, G. P. D. R., Silva, L. F., & Oppenheimer, D. (2023) · Research Society and Development · doi:10.33448/rsd-v12i10.43354 · Cited by 5
Should we treat mild gestational diabetes? An Australian multicentre retrospective cohort study
Rudland, V. L., Hibbert, E., Flack, J. R., Wong, T., Wong, V., McLean, M. P., Pasupathy, D., Simmons, D. S., & Cheung, N. W. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02548-6 · Cited by 1
Follow-up and risk factors of pregnant women with gestational diabetes in Morocco
Boutiti, R., Gougueni, H., Bouchriti, Y., Arechkik, A., Mahlaq, S., Iziki, H., & Barkat, A. (2025) · Journal of Public Health in Africa · doi:10.4102/jphia.v16i1.1313 · Cited by 2
Hallack, C., Nogueira, B. V., Bomfim, M. D. L., Meireles, N. G., & Martins, W. P. (2026) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2026rbgo18 · Cited by 1
“(11,19,20) 21-23) It is important to note that metformin crosses the placenta freely, (10) and the short-term effects on these fetuses indicate that metformin is safe while the long-term effects are still unknown.”
Educational interventions to improve maternal‐foetal outcomes in women with gestational diabetes
Lapertosa, S., Elgart, J. F., González, C. D., Alvariñas, J., Camin, P., Mezzabotta, L., Salzberg, S., & Gagliardino, J. J. (2021) · Lifestyle Medicine · doi:10.1002/lim2.18 · Cited by 1
Abbas, A. M., El-Wafa, S. A., & El-Sabaa, H. (2021) · Evidence Based Women s Health Journal · doi:10.21608/ebwhj.2021.51653.1117 · Cited by 1
“Metformin shouldn’t be used in those with impaired kidney or liver functions due to rare risk of lactic acidosis associated with metformin, and this risk increase with these two conditions[14].”
BackgroundThe High-Risk Obstetric Patient: Pregnancy-Induced Conditions
Curbelo, J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780190099824.003.0007 · Cited by 1
O uso da metformina no tratamento do Diabetes Mellitus Gestacional
Duarte, B. R., CALIAN, G. S., RODRIGUES, L. A., ALBERTINO, N. C. N., SANTOS, P. P. R. D., & Vasconcellos, M. (2020) · Multidisciplinary Reviews · doi:10.29327/multi.2021003 · Cited by 1
Enhanced Recovery After Surgery Programs in Cesarean Delivery: Review of the Literature
Kınay, T., İbanoğlu, M. C., & Üstün, Y. E. (2022) · Türk Kadın Sağlığı ve Neonatoloji Dergisi · doi:10.46969/ezh.1076419 · Cited by 3
Benton, M., Payne, E., Waheed, N., Turner, K., Murphy, H. R., Skouteris, H., Ismail, K., & Silverio, S. A. (2025) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.70038
“Consequently, GDM pregnancies can become highly medicalised (Diane et al. 2017).”
Treatment of Gestational Diabetes
Maged, A. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86988
Samiun, N. A. A., Yusof, B. N. M., Ismail, I. Z., Anuar, F., & Chee, W. S. S. (2019) · Journal of Clinical and Health Sciences · doi:10.24191/jchs.v4i2.7511 · Cited by 1
“Individualised nutrition education improved nutritional status, clinical, and pregnancy outcomes in women with GDM [4, 11, 12].”
BackgroundRisk factors for neonatal hypoxic ischemic encephalopathy in Helsinki University Hospital
Roto, S. (2020) · Työväentutkimus Vuosikirja
Metformin versus Insulin in Treatment of Gestational Diabetes
HAYANI, A. N. A. A. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.118554 · Cited by 2
Abdullah, A., Gabr, A. A., Hamed, D., & Eweis, M. (2021) · Evidence Based Women s Health Journal · doi:10.21608/ebwhj.2021.82768.1144 · Cited by 2
The Gestational Diabetes Mellitus Approach in Clinical Practice – A Narrative Review
Deteșan, O., Custură, L. M., Schmiedt, R. A., Bacso, B. I., Bell, A. C., Streza, M. A., & Tilinca, M. C. (2021) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2021-0037
Metformin in the management of gestational diabetes
Rotar, I. C., Stănică, B., Petca, A. T., & Mureșan, D. (2022) · Obstetrica şi Ginecologia · doi:10.26416/obsgin.70.2.2022.6682
Fung, S. S.-P. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-024-01047-y
“However, in the two largest meta-analyses it was noted that many of the trials involving metformin were small, had a high or unclear risk of bias and had differences in the packages of care between treatment arms making it difficult to assess the contribution of treatment to efficacy [31, 32].”
Mor, L., Toledano, E., Shoshan, N. B., Weiner, E., Paz, Y. G., Barda, G., & Levy, M. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07455-9 · Cited by 3
“While the United States Preventive Services Task Force advocates for a significant advantage in diagnosing and treating GDM using current methodologies [2, 3], the merit of these diagnostic and treatment strategies is still disputed by many in the field [4, 5].”
Features of Hypoglycemic Pharmacotherapy of Gestational Diabetes Mellitus
Чак, Т. А., Высоцкая, Ю. В., Романова, И. С., & Кожанова, И. Н. (2023) · Рецепт · doi:10.34883/pi.2023.26.6.011
Jankar, J. S., Manglaram, A., Ahmed, T., & Yadav, A. S. (2024) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2024.061
Gestational diabetes mellitus: ensuring healthy futures
Morgan, H. D., Hamza, M., Morrison, A., Campbell, C., Cassar, C. B., Thayyil, S., & Meek, C. L. (2024) · British Journal of Midwifery · doi:10.12968/bjom.2024.0054
Monemi, E., Tingström, J., Sterpu, I., & Wiberg‐Itzel, E. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.01.031
Treatment Effects of the Integrated Perinatal Diabetes Education and Management Program
Patchen, L., McCullers, A., Budd, S. G., Browning, M., Mathur, S., Wu, K., Dills, R., Silagi, S., Welch, J., & Greenberg, V. (2025) · Diabetes Spectrum · doi:10.2337/ds24-0076
Kinnunen, J., Nikkinen, H., Keikkala, E., Mustaniemi, S., Gissler, M., Laivuori, H. M., Eriksson, J. G., Kajantie, E., & Vääräsmäki, M. (2025) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.70077
“17 In this study, GDM was identified based on MBR data indicating at least one of the following: abnormal OGTT during pregnancy, initiation of insulin therapy during pregnancy, or a GDM diagnosis (ICD-10: O24.”
Gestational Diabetes and Type 2 Diabetes during Pregnancy
Bond, R., & Peters, T. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00050-8
Roto, S., Nupponen, I. K., Kalliala, I. E. J., & Kaijomaa, M. (2024) · Figshare · doi:10.6084/m9.figshare.26027600
Markussen, L. T., Kivelä, J., Lindström, J., Ashrafi, R. A., Heinonen, S. T., Koivusalo, S. B., & Meinilä, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.23689439
GDM diagnostic criteria in use in the Mediterranean region
Craus, J., Savona Ventura, C., Vassallo, J., & MGSD, E. S. G. (2024) · Malta Medical Journal
Objective Standards of Medical Judgment: A Myth of (Texas) Abortion Law
Graber, A. D., Peterson, M., & Detrick, E. (2026) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2025.10208 · Cited by 1
Temas selectos de ginecología y obstetricia
Tamaulipas, U. A., & Cárdenas, J. E. G. (2026) · doi:10.29059/luat.479
Goedeke, S. M. (2024) · Tuwhera (Auckland University of Technology)
Bhujbal, M. P., Dwivedi, J., Rane, P. B., & Mayadeo, N. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20261263
Pharmacologic Treatment of Diabetes in Pregnancy
Feghali, M. N. (2026) · Clinics in Perinatology · doi:10.1016/j.clp.2026.04.006
Barry, C.-J. S., Zuber, V., Lawlor, D. A., Borges, M. C., Sanderson, E. C. M., & Shapland, C. Y. (2026) · Genetic Epidemiology · doi:10.1002/gepi.70043
“This result is not surprising as glucose is a well‐established maternal metabolite driving offspring birthweight as reported by both RCTs (Farrar et al. 2017) and MR studies (Barry et al. 2022; Tyrrell et al. 2016; Chen et al. 2020).”
Self-citationRISK FACTORS, INCIDENCE AND TREATMENT OF HYPOGLYCEMIA IN THE NEWBORN
Karjalainen, E. (2023) · UEF eRepo (University of Eastern Finland)
Ajay Kumar Gupta, A. M., Mishra, A., & Katiyar, P. (2024) · Journal of chemical health risks
Yamini Patil, A. P. (2023) · Pakistan Heart Journal
Al-Nemer, K., Alruwaili, H. M., Alnashwan, A., Akram, M., Almuzaini, M., Aloraini, A., Alsaedi, R., Alshammari, B. B., Almasoud, L., Alsulami, M., et al. (2026) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2277_25
“Previous reviews have similarly indicated that up to 40% of women started on metformin may require insulin augmentation, [28] underscoring the importance of individualized treatment plans and close glucose monitoring.”
Metadata
- Authors
- Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A.
- Affiliations
- Bradford Royal Infirmary (GB)
- University of York (GB)
- University of Leeds (GB)
- Bradford Teaching Hospitals NHS Foundation Trust (GB)
- University of Bristol (GB)
- Corresponding author
- Farrar, Diane
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-06
- Volume
- 7
- Issue
- 6
- Pages
- e015557
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC5734427
- OpenAlex
- W2626502458
- Cited by
- 163
- References
- 83
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 17 · 2023: 22 · 2022: 22 · 2021: 26 · 2020: 17 · 2019: 16 · 2018: 16 · 2017: 2
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMJ Open (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion, public-domain)
- HighWire Press Open Archive (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Funders
- Health Technology Assessment Programme
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, treatment effectiveness, insulin therapy, metformin, glibenclamide, dietary and lifestyle interventions, perinatal outcomes, large for gestational age, shoulder dystocia, neonatal hypoglycemia, cesarean section, preeclampsia
- MeSH terms
- Bayes Theorem, Cesarean Section, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Randomized Controlled Trials as Topic, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.